Crispr Therapeutics Stays Costly With Slower Casgevy Monetization And Patent Battle
Andy CRSP's Gene Modifying Expertise Has Lastly Been Accepted CRSP's Gene Modifying Expertise CRSP CRISPR Therapeutics AG (NASDAQ:CRSP) is a ...
Monday, December 16, 2024
Tag: Casgevy
Impact Of Gene Therapies And Casgevy On Crispr AG And The Industry (CRSP)
Bill Oxford CASGEVY approval CASGEVY is a groundbreaking gene therapy, owned by CRISPR Therapeutics AG (CRSP) and Vertex (VRTX) specifically ...
Vertex announces Saudi Arabian approval of Casgevy for sickle cell, TDT (NASDAQ:VRTX)
Hailshadow Vertex Pharmaceuticals (NASDAQ:VRTX) said its gene therapy Casgevy has been approved by Saudi Arabian regulators for the treatment of ...
RECOMMENDED
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.